E-LIB Suche - Ergebnisse für: Sarsour, Khaled

1

Enhancing site selection strategies in clinical trial recru..:

Hulstaert, Lars ; Twick, Isabell ; Sarsour, Khaled..
PLOS ONE. 19 (2024) 3 - p. e0300109 , 2024

Link: https://doi.org/10.1371/..

2

Assessing ascertainment bias in atrial fibrillation across ..:

Hulstaert, Lars ; Boehme, Amelia ; Hood, Kaitlin...
PLOS ONE. 19 (2024) 4 - p. e0301991 , 2024

Link: https://doi.org/10.1371/..

3

2659. Substantially Elevated Influenza Risk in Vaccinated I..:

Zemlianskaia, Natalia ; Zheutlin, Amanda ; Murata, Yoshihiko...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

External Comparator Groups Derived from Real-world Data Use..:

Carrigan, Gillis ; Bradbury, Brian D. ; Brookhart, M. Alan...
Current Epidemiology Reports. 9 (2022) 4 - p. 326-337 , 2022

Link: https://doi.org/10.1007/..

5

Durability of Protection Post–Primary COVID-19 Vaccination ..:

Zheutlin, Amanda ; Ott, Miles ; Sun, Ran...
Vaccines. 10 (2022) 9 - p. 1458 , 2022

Link: https://doi.org/10.3390/..

6

Impact of Immune Checkpoint Inhibitors on COVID-19 Severity..:

Tan, Ruoding ; Yun, Cindy ; Seetasith, Arpamas...
The Oncologist. 27 (2022) 3 - p. 236-243 , 2022

Link: https://doi.org/10.1093/..

7

Durability of Protection Post–Primary COVID-19 Vaccination ..:

Amanda Zheutlin ; Miles Ott ; Ran Sun...
COVID-19 Vaccines and Vaccination. , 2022

Link: https://doi.org/10.3390/..

8

Durability of Protection Post–Primary COVID-19 Vaccination ..:

Amanda Zheutlin ; Miles Ott ; Ran Sun...
https://www.mdpi.com/2076-393X/10/9/1458. , 2022

Link: https://doi.org/10.3390/..

9

Association of biological antirheumatic therapy with risk f..:

Paul, Sanjoy K ; Montvida, Olga ; Best, Jennie H...
BMJ Open. 11 (2021) 6 - p. e042246 , 2021

Link: https://doi.org/10.1136/..

10

Association of biological antirheumatic therapy with risk f..:

Paul, Sanjoy K ; Montvida, Olga ; Best, Jennie H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211068/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Association of biological antirheumatic therapy with risk f..:

Attila Pethö-Schramm ; Sara Gale ; Khaled Sarsour...
https://bmjopen.bmj.com/content/11/6/e042246.full. , 2021

Link: https://doi.org/10.1136/..

12

Rituximab utilization for approved and off‐label nononcolog..:

Sarsour, Khaled ; Beckley‐Kartey, Senam ; Melega, Simone...
Pharmacology Research & Perspectives. 8 (2020) 1 - p. , 2020

Link: https://doi.org/10.1002/..

13

Rituximab utilization for approved and off‐label nononcolog..:

Sarsour, Khaled ; Beckley‐Kartey, Senam ; Melega, Simone...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941895/. , 2020

Link: http://www.ncbi.nlm.nih...

14

Rituximab utilization for approved and off‐label nononcolog..:

Khaled Sarsour ; Senam Beckley‐Kartey ; Simone Melega...
https://doi.org/10.1002/prp2.555. , 2020

Link: https://doi.org/10.1002/..

15

Risk of malignancy associated with use of tocilizumab versu..:

Kim, Seoyoung C. ; Pawar, Ajinkya ; Desai, Rishi J....
Seminars in Arthritis and Rheumatism. 49 (2019) 2 - p. 222-228 , 2019

Link: https://doi.org/10.1016/..